First Time Loading...

Agenus Inc
NASDAQ:AGEN

Watchlist Manager
Agenus Inc Logo
Agenus Inc
NASDAQ:AGEN
Watchlist
Price: 13.26 USD 9.41%
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

AGEN Price Targets Summary
Agenus Inc

Wall Street analysts forecast AGEN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AGEN is 5.61 USD with a low forecast of 3.03 USD and a high forecast of 8.4 USD.

AGEN Lowest Forecast
Wall Street Target
3.03 USD
77% Downside
AGEN Average Forecast
Wall Street Target
5.61 USD
58% Downside
AGEN Highest Forecast
Wall Street Target
8.4 USD
37% Downside
Lowest
Price Target
3.03 USD
77% Downside
Average
Price Target
5.61 USD
58% Downside
Highest
Price Target
8.4 USD
37% Downside
Agenus Inc Competitors:
Price Targets
688687
Beijing Kawin Technology Share-holding Co Ltd
33% Upside
PBYI
Puma Biotechnology Inc
11% Downside
KNTE
Kinnate Biopharma Inc
9% Downside
6855
Ascentage Pharma Group International
74% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
33% Upside
PBYI
Puma Biotechnology Inc
11% Downside
KNTE
Kinnate Biopharma Inc
9% Downside
6855
Ascentage Pharma Group International
74% Upside
M
MGX
Metagenomi Inc
287% Upside
I
086890
Isu Abxis Co Ltd
122% Upside
603387
Getein Biotech Inc
298% Upside
XNCR
Xencor Inc
56% Upside

Revenue
Forecast

Revenue Estimate
Agenus Inc

For the last 8 years the compound annual growth rate for Agenus Inc's revenue is 26%. The projected CAGR for the next 3 years is 25%.

26%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Agenus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Agenus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-72%
Average Miss
What are analyst estimates?

See Also

Summary
AGEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
AGEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AGEN stock valuation using valuation multiples.
Wall Street Estimates
AGEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AGEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AGEN's stock price target?
Price Target
5.61 USD

According to Wall Street analysts, the average 1-year price target for AGEN is 5.61 USD with a low forecast of 3.03 USD and a high forecast of 8.4 USD.

What is Agenus Inc's Revenue forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Agenus Inc's revenue is 26%. The projected CAGR for the next 3 years is 25%.

ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.